Skip to main content
. 1998 Jan;111(1):158–165. doi: 10.1046/j.1365-2249.1998.00448.x

Fig. 1.

Fig. 1

Measurement of HLA-DQ2 surface expression on HLA-negative K562 erythroleukaemic cell line (a) (mean fluorescence 1.248) and B cells from a coeliac disease patient homozygous for HLA-DR3, -DQ2 (b) (mean fluorescence 14.14) using anti-DQ (SPV-L3; Serotec), and FITC-conjugated goat anti-mouse (Becton Dickinson) MoAbs, by FACS analysis.